[Epidemiology of Pseudomonas aeruginosa infections in a unit for the treatment of renal failure].
D058186:Acute Kidney Injury / Q000628:therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D000391:Air Microbiology; D000667:Ampicillin / Q000494:pharmacology; D001202:Ascitic Fluid / Q000382:microbiology; D001430:Bacteriocins; D001548:Benzalkonium Compounds / Q000009:adverse effects; D002404:Catheterization; D002509:Cephaloridine / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D003428:Cross Infection / Q000209:etiology*; D005027:Ethylene Oxide; D005374:Filtration; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008242:Lysogeny; D008875:Middle Aged; D009268:Nalidixic Acid / Q000494:pharmacology; D010530:Peritoneal Dialysis; D011552:Pseudomonas Infections / Q000453:epidemiology* / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*; D006435:Renal Dialysis; D013242:Sterilization; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014466:Ultraviolet Rays; D014552:Urinary Tract Infections / Q000150:complications
D001430:Bacteriocins; D001548:Benzalkonium Compounds; D005839:Gentamicins; D009268:Nalidixic Acid; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D005027:Ethylene Oxide; D002509:Cephaloridine; D013307:Streptomycin; D003091:Colistin
Epidémiologie des infections à bacille pyocyanique (Ps. aeruginosa) dans un centre de traitement de l'insuffisance rénale.